MOHCY yields 5.18% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, MOHCY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MOHCY + JNJ for your $10,000?
Motor Oil (Hellas) Corinth Refineries S.A. engages in oil refining and oil products trading in Greece and internationally. It operates through four segments: Refining Activity, Fuels' Marketing Activity, Power & Gas, and Other. The company produces and sells liquid fuels, lubricants, and asphalt for transportation, industrial, and household use. It also markets and distributes a range of oil products, including gasoline, fuel oil, diesel, and lubricants through a retail network of approximately 796 stations under the SHELL name; retail service comprising 24 SHELL branded fuel sites; and operates 531 gas stations under AVIN brand name and 111 gas stations under CYCLON brand. In addition, the company engages in oil trading, storage agency, and services; collection and trading of used lubricants; research, exploration, and trading of crude oil; and marketing and distribution of liquefied petroleum gas, as well as operates aircraft fuel supply system and the storage facilities at the Athens International Airport at Spata of Attica. Further, it is involved in the purchase, sale, exploitation, and development of real estate properties; and provision of liquefied petroleum gas, facilities management services, and financial services, as well as systems of alternative management of lubricant wastes. The company was founded in 1970 and is headquartered in Marousi, Greece.
Full MOHCY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.